Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study

Detalhes bibliográficos
Principais autores:	Garriga, C, Pazianas, M, Hawley, S, Delmestri, A, Prieto-Alhambra, D, Cooper, C, Judge, A
Formato:	Conference item
Publicado em:	Springer London 2018

Registros relacionados

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
por: Garriga, C, et al.
Publicado em: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
por: Garriga, C, et al.
Publicado em: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
por: Garriga, C, et al.
Publicado em: (2017)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
por: Strauss, V, et al.
Publicado em: (2018)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
por: Prieto-Alhambra, D, et al.
Publicado em: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
por: Prieto-Alhambra, D, et al.
Publicado em: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
por: Prieto-Alhambra, D, et al.
Publicado em: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
por: Prieto-Alhambra, D, et al.
Publicado em: (2012)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
por: Hawley, S, et al.
Publicado em: (2014)

Descriptive epidemiology of hip and knee replacement among rheumatoid arthritis patients in England and Wales: variation by age, sex, geography and socioeconomic status
por: Hawley, S, et al.
Publicado em: (2017)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
por: Hawley, S, et al.
Publicado em: (2018)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
por: Reyes, C, et al.
Publicado em: (2015)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
por: Prieto-Alhambra, D, et al.
Publicado em: (2014)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
por: Prieto-Alhambra, D, et al.
Publicado em: (2011)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
por: Robinson, DE, et al.
Publicado em: (2021)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
por: Ali, MS, et al.
Publicado em: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
por: Robinson, DE, et al.
Publicado em: (2021)

Total hip and knee replacement among incident osteoarthritis and rheumatoid arthritis patients within the UK Clinical Practice Research Datalink (CPRD) compared to hospital episode statistics (HES): a validation study
por: Hawley, S, et al.
Publicado em: (2016)

Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records
por: Hawley, S, et al.
Publicado em: (2019)

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK
por: Khalid, S, et al.
Publicado em: (2019)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
por: Round, G, et al.
Publicado em: (2012)

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
por: Robinson, D, et al.
Publicado em: (2018)

Safety of bisphosphonates.
por: Pazianas, M, et al.
Publicado em: (2011)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
por: Robinson, DE, et al.
Publicado em: (2021)

Atrial fibrillation and the use of oral bisphosphonates.
por: Pazianas, M, et al.
Publicado em: (2011)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
por: Ali, M, et al.
Publicado em: (2018)

Association of sildenafil use with age-related macular degeneration: a retrospective cohort study
por: Nicola Jaime Adderley, et al.
Publicado em: (2024-04-01)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
por: Round, G, et al.
Publicado em: (2012)

Effect of intra-articular corticosteroid injections for osteoarthritis on the subsequent use of pain medications: a UK CPRD cohort study
por: Hawley, S, et al.
Publicado em: (2025)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
por: Pazianas, M, et al.
Publicado em: (2010)

Atrial fibrillation and bisphosphonate therapy.
por: Pazianas, M, et al.
Publicado em: (2010)

Atrial fibrillation and the use of oral bisphosphonates
por: Michael Pazianas, et al.
Publicado em: (2011-03-01)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
por: Shah, A, et al.
Publicado em: (2016)

Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
por: Shah, A, et al.
Publicado em: (2016)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
por: Shah, A, et al.
Publicado em: (2016)

Patient-Centered Economic Burden of Exudative Age-Related Macular Degeneration: Retrospective Cohort Study
por: Kyungseon Choi, et al.
Publicado em: (2023-12-01)

Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
por: Hawley, S, et al.
Publicado em: (2016)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
por: Hawley, S, et al.
Publicado em: (2020)

Oral bisphosphonates and chronic kidney disease: progression and safety
por: Prieto-Alhambra, D, et al.
Publicado em: (2018)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
por: Prieto-Alhambra, D, et al.
Publicado em: (2011)